The ready-to-use lentiviral particles of Lenti-pp65 TCR (MD-19)-VP is packaged using 3rd generation of lentiviral packaging system, in which the gene of Human TCR will be driven by a CMV promotor. The target gene of TCR packaged in lentiviral particles could be used for high efficency tranduction of T cells and stably integrated expression.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|TCR-L139||Human anti-CMV pp65 T cell receptor (TCRCD8-CMV#4), pCDTCR1|
|TCR-L138||Human anti-CMV pp65 T cell receptor (TCRCD8-CMV#1), pCDTCR1|
|VP-TCR-C433||Lenti-pp65 T cell receptor (C25) Viral Particle|
|VP-TCR-C432||Lenti-pp65 T cell receptor (C7) Viral Particle|
|TCR-C218Z||Human anti-pp65 T cell receptor (Codon optimized), pCDTCR1|
|TCR-L099Z||Human anti-pp65 (aa417-426) T cell receptor (Codon optimized and cysteine modified), pCDTCR1|
|TCR-L100Z||Human anti-pp65 (aa265-275) T cell receptor (Codon optimized and cysteine modified), pCDTCR1|
|TCR-L097||Human anti-pp65 (NLVPMVATV) T Cell Receptor, pLXSN|
|VP-TCR-C436||Lenti-pp65 T cell receptor (Codon optimized and cysteine modified) Viral Particle|
|VP-TCR-C439||Lenti-HCMV pp65 T cell receptor (TCRCD8-CMV#8) Viral Particle|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved